Search

ResMed Inc

Ouvert

SecteurSoins de santé

228.47 -0.7

Résumé

Variation du prix de l'action

24h

Actuel

Min

226.93

Max

232.73

Chiffres clés

By Trading Economics

Revenu

1.1B

1.5B

Ventes

32M

1.5B

P/E

Moyenne du Secteur

21.5

57.371

BPA

2.95

Rendement du dividende

1.07

Marge bénéficiaire

104.075

Employés

11,370

EBITDA

-91M

493M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+3.4% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

1.07%

2.23%

Prochains Résultats

29 oct. 2026

Date du Prochain Dividende

24 sept. 2026

Date du Prochain Détachement de Dividende

20 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

574M

32B

Ouverture précédente

229.17

Clôture précédente

228.47

Sentiment de l'Actualité

By Acuity

35%

65%

117 / 340 Classement par Healthcare

ResMed Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 août 2026, 20:02 UTC

Shares of Resmed Inc. are trading higher today, reflecting strong momentum and significant recovery from earlier session dips.

18 août 2026, 19:41 UTC

News

ResMed Inc. plans a meeting with KeyBanc on August 26 in Montreal. Shares are trading higher since Monday's close, recovering from earlier fluctuations.

17 août 2026, 20:06 UTC

News

ResMed Inc. shares are declining following a Q2 earnings report showing reduced operating margins and a $42 million charge related to safety actions.

14 août 2026, 23:46 UTC

Resmed Inc. shares are lower in after-market hours amid broader market sentiment influenced by a surprising decline in U.S. retail sales for July.

13 août 2026, 19:16 UTC

News

ResMed Inc reports Q2 revenue of $1.46 billion, matching estimates. Shares are higher amid investor sentiment despite challenges from rising costs and a safety charge.

12 août 2026, 21:01 UTC

Resmed Inc. shares are trading lower in after-market hours, continuing a decline that began shortly after Wednesday's close. No specific news was identified.

11 août 2026, 23:26 UTC

Resmed Inc. shares remained roughly flat in after-market hours, reflecting broader market conditions amid investor caution ahead of upcoming inflation data.

10 août 2026, 20:02 UTC

Social Media
News

ResMed reported Q2 2026 sales of $1.46 billion, exceeding expectations. Shares are gaining today, despite earlier pulling back in the session.

8 août 2026, 00:01 UTC

Resmed Inc. shares declined in after-market trading, moving below the 20-day moving average, despite earlier gains since Friday's close.

7 août 2026, 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6 août 2026, 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5 août 2026, 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4 août 2026, 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

3 août 2026, 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

31 juil. 2026, 21:01 UTC

Resmed Inc shares advanced in after-market trading, significantly above their 20-day moving average. No specific news was identified to explain the increase.

30 juil. 2026, 19:55 UTC

ResMed Inc's shares are declining today, diverging from a broader tech recovery. No specific news was identified to explain the move.

29 juil. 2026, 19:04 UTC

ResMed Inc's shares are higher Wednesday, reflecting overall upward momentum since Tuesday's close, despite a recent pullback from session highs.

28 juil. 2026, 19:02 UTC

Shares of Resmed Inc. are higher today, driven by gains in Health Care Equipment stocks. No specific news was identified to explain this increase.

27 juil. 2026, 22:26 UTC

Resmed Inc shares are trading higher in after-hours activity, remaining above their 20-day moving average despite no specific news driving the price movement.

24 juil. 2026, 16:03 UTC

ResMed Inc shares are higher today, driven by gains in the Health Care Equipment sub-sector, despite earlier volatility and recent underperformance.

22 juil. 2026, 23:16 UTC

Resmed Inc shares are trading higher in after-market hours, rebounding from an initial dip and showing unusual strength compared to typical performance.

21 juil. 2026, 20:56 UTC

Resmed Inc. shares are trading roughly flat after-market, amid broader market optimism following positive earnings from 3M and General Motors.

20 juil. 2026, 19:16 UTC

ResMed Inc shares are lower today, continuing a downward trend since Friday. The stock briefly hit a session high earlier but has since declined.

Comparaison

Variation de prix

ResMed Inc prévision

Objectif de Prix

By TipRanks

3.4% hausse

Prévisions sur 12 Mois

Moyen 238.5 USD  3.4%

Haut 320 USD

Bas 213 USD

Basé sur 15 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

15 ratings

4

Achat

11

Maintien

0

Vente

Sentiment

By Acuity

117 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat